Genepharm

Genepharm, established in 1967, is primarily engaged in the development, production, and marketing of high-value generic drugs. The company focuses on ten core therapeutic areas, including cardiology, dermatology, neurology, oncology, and urology, and operates three state-of-the-art pharmaceutical manufacturing facilities dedicated to producing conventional solid dosage forms, sterile liquid oncology products, and solid dosage forms. With a presence in over ninety countries worldwide, Genepharm is recognized as one of the leading pharmaceutical companies globally.